MTP Session I: AML- Menin Inhibition   

Session Chair: Ghayas C. Issa, MD

• Overview of Menin Inhibitors in KMT2Ar, NPM1m and Other HOX Expressing Leukemias |  Ghayas C. Issa, MD | MD Anderson Cancer Center, Houston, Texas, USA
• Menin Inhibitors – Mechanisms of Resistance | Jolanta Grembecka, PhD | University of Michigan, Ann Arbor, Michigan, USA
• Menin Inhibitor Combinations – Ongoing Trials | Joshua Zeidner, MD | University of North Carolina, Chapel Hill, North Carolina, USA